Nuvation Bio has secured up to $250 million in non-dilutive financing from Sagard Healthcare Partners, marking a significant funding milestone for the biotechnology firm. In related news, the private equity landscape is showing signs of recovery, with global private equity deal-making increasing by 14% in 2024 to reach $2 trillion, the highest capital deployment since 2022. This uptick comes as U.S. venture capital firms raised $76.1 billion in 2024, the lowest amount since 2019, with established players capturing the majority of the funding. Additionally, CVC Capital Partners has successfully raised €4.61 billion for its latest private equity fund focused on long-term investments, while Sofinnova Partners has raised €1.2 billion to support life sciences innovation, bringing its total assets under management to over €4 billion.